Highlights from our recent research
We analyse how PSAK 117 has materially reshaped the way Indonesian conventional insurers report their financial performance and position.

With the expansion of the Medicare Drug Price Negotiation Program to include Part B drugs for 2028, stakeholders need to understand the expected impacts.
We recap FASB’s November decision to use the interest crediting rate for market-based cash balance plan accounting.